Erythema annulare centrifugum

L12_ERYTH_ANNULCENTRIFUG

erythema infectiosum: usually a benign childhood condition characterized by a classic slapped-cheek appearance (see the image below) and lacy exanthem.It results from infection with human parvovirus (PV) B19, an erythrovirus.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L53.1 Hospital discharge: ICD-9 — 6958B Hospital discharge: ICD-8 — 69591 Cause of death: ICD-10 — L53.1 Cause of death: ICD-9 — 6958B Cause of death: ICD-8 — 69591 2 out of 7 registries used, show all original rules.	61
4. Check minimum number of events None	61
5. Include endpoints None	61
6. Filter based on genotype QC (FinnGen only)	61

Control definitions (FinnGen only)

Control exclude: L12_URTICARIAERYTHEMA

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L53
Name in latin: Erythema anulare centrifugum

NAME	L12_ERYTH_ANNULCENTRIFUG
CONTROL_EXCLUDE	L12_URTICARIAERYTHEMA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L531
HD_ICD_9	6958B
HD_ICD_8	69591
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L531
COD_ICD_9	6958B
COD_ICD_8	69591
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Erythema annulare centrifugum based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	491	327	161
Only index persons	439	297	142
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.00
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	55.65	56.35	53.95
Only index persons	54.82	55.33	53.75

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	61	44	17
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	56.92	55.06	61.74

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
54: Matched controls
539

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L53.1

ICD-10 Finland

Erythema annulare centrifugum

+∞

72.2

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

10.0

D07AC13

ATC

mometasone; topical

5.8

8.1

L30.9

ICD-10 Finland

Dermatitis, unspecified

6.9

8.0

D07AC01

ATC

betamethasone; topical

4.4

6.3

133

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40768443) Skin Pathology biopsy report

5.98

6.03

1.3

—

(3032080) INR in Blood by Coagulation assay

185

2.89

4.00

20.9

9.0

1.3

1.2

inr

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

177

2.88

3.99

3.4

4.3

20.8

20.6

ng/l

0.01

117

(3015736) pH of Urine

200

2.76

3.66

4.1

3.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

5.96

3.31

1.3

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

197

2.31

2.60

5.7

4.0

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

7.64

2.59

2.4

2.7

—

(42870588) Differential panel, method unspecified - Blood

164

2.31

2.55

6.5

5.2

—

(3029937) Albumin [Presence] in Urine by Test strip

132

2.35

2.52

5.7

4.2

0.0

estimate

—

(3021601) Nitrite [Presence] in Urine by Test strip

247

2.27

2.43

7.2

5.4

0.0

estimate

—

(3009261) Glucose [Presence] in Urine by Test strip

247

2.27

2.43

5.5

3.9

0.0

estimate

—

(3035350) Ketones [Presence] in Urine by Test strip

247

2.27

2.43

5.4

3.9

0.0

estimate

—

(3021440) Promyelocytes/100 leukocytes in Blood

3.04

2.23

9.1

3.7

0.2

0.3

—

(3023368) Bacteria identified in Blood by Culture

116

2.24

2.13

5.0

4.3

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2.68

2.10

5.1

4.0

254.1

237.0

u/l

0.27

(3014007) Fractional oxyhemoglobin in Arterial blood

4.04

1.99

5.8

11.4

95.6

95.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

4.84

1.98

2.8

5.5

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

112

2.17

1.95

3.8

3.7

—

(3017181) Myelocytes/100 leukocytes in Blood

2.79

1.95

9.3

3.5

1.3

0.9

—

(3022145) Colonoscopy Study observation

2.41

1.94

1.0

1.4

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

179

2.04

1.94

5.1

2.9

—

(3026008) Bacteria identified in Urine by Culture

154

2.06

1.90

2.3

3.0

—

(4010399)

3.02

1.87

1.3

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

4.09

1.75

1.6

2.2

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

3.38

1.70

2.2

1.3

1.1

1.3

g/l

—

(3020961) Endomysium IgA Ab [Titer] in Serum

3.38

1.70

1.2

1.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

3.79

1.65

10.8

1.5

—

(3019060) Gas panel - Arterial blood

2.63

1.60

3.8

5.4

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2.46

1.48

4.6

7.9

119.1

123.6

g/l

—

(3018418) pH of Serum or Plasma

158

1.86

1.45

4.9

3.8

7.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

2.27

1.43

1.9

1.6

—

(3037467) Urinalysis macro (dipstick) panel - Urine

330

1.88

1.42

6.4

4.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

216

1.77

1.33

4.6

4.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2.93

1.31

2.4

1.3

0.2

0.3

g/l

—

(3045414) Leukocytes [Presence] in Urine

2.93

1.31

1.8

1.7

—

(3019832) Treponema pallidum Ab [Presence] in Serum

2.40

1.30

1.8

1.5

—

(3023520) Reticulocytes [#/volume] in Blood

2.27

1.24

4.3

2.9

83.5

66.2

e9/l

—

(4035726)

2.27

1.24

1.9

1.3

—

(40761535) Cells panel - Urine sediment

2.27

1.24

3.8

3.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1.96

1.18

1.9

1.7

—

(3000330) Specific gravity of Urine by Test strip

2.63

1.17

6.6

3.9

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.98

1.14

1.8

1.6

—

(40760892) CBC W Ordered Manual Differential panel - Blood

117

1.76

1.10

13.8

5.0

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

400

1.76

1.02

11.2

7.8

81.6

78.6

u/l

0.17

370

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.94

1.02

4.2

4.6

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.89

1.00

1.6

1.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2.35

0.96

2.3

2.1

—

(40761536) Microorganisms panel - Urine sediment

2.04

0.93

6.8

4.3

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

2.11

0.89

4.7

5.5

1.5

1.6

mmol/l

—

(3013512) EKG study

143

1.59

0.85

4.5

3.9

—

(3037522) Nuclear Ab [Titer] in Serum

1.70

0.75

1.5

1.4

192.0

760.0

titre

—

(3012544) pH of Venous blood

1.85

0.74

6.6

3.2

—

(36660697) Celiac disease serology panel - Serum

1.80

0.73

1.3

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1.75

0.71

6.6

5.5

1.2

mmol/l

—

(3012516) Albumin [Mass/volume] in Urine

149

1.51

0.70

4.8

3.2

9.1

52.9

mg/l

1.58

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

496

1.77

0.66

4.9

4.8

6.0

5.9

mmol/l

0.35

462

(3020682) Albumin/Creatinine [Ratio] in Urine

160

1.48

0.66

6.7

3.9

1.5

10.3

mg/mmol

1.51

(3041096) Erythrocytes [Presence] in Urine by Automated

142

1.49

0.65

6.2

3.7

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.61

0.0

1.1

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.85

0.60

1.8

1.4

—

(3003694) ABO and Rh group [Type] in Blood

126

1.48

0.60

1.4

1.5

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

492

1.59

0.52

20.0

14.1

14.7

22.4

mg/l

1.49

374

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

195

1.38

0.52

2.3

2.0

77.3

95.9

pmol/l

1.20

(40758558) Short blood count panel - Blood

130

1.43

0.51

5.0

6.0

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

481

1.55

0.50

4.7

4.0

1.4

1.3

mmol/l

0.72

444

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.52

0.49

1.3

2.1

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

170

1.36

0.46

4.1

3.6

28.7

30.0

u/l

0.13

161

(3000991) Gas panel - Venous blood

1.61

0.43

8.0

5.7

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1.56

0.42

1.0

1.2

—

(3008898) HLA-B27 [Presence]

0.00

0.41

0.0

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.41

0.0

1.7

—

182.2

—

(3036489) Thrombin time

0.00

0.41

0.0

1.6

—

20.4

—

(3044889) 12 lead EKG panel

360

1.32

0.41

3.1

3.9

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1.40

0.37

1.6

1.4

—

(40761511) CBC panel - Blood by Automated count

522

1.54

0.36

19.2

12.7

—

(3000492) Spirometry study

1.40

0.35

1.2

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.36

0.32

10.4

6.3

—

(3002256) Pathology report gross observation

1.27

0.27

1.3

1.2

—

(3044640) Blood type and Crossmatch panel - Blood

143

1.26

0.27

2.5

2.0

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

466

0.80

0.25

20.9

13.6

77.7

81.8

ml/min/173m2

0.71

380

(3009542) Hematocrit [Volume Fraction] of Blood

456

0.81

0.25

17.0

14.4

35.1

39.9

0.87

331

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.30

0.24

2.2

1.6

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.0

—

3.8

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

0.00

0.21

0.0

1.4

—

(3011288) Drugs identified in Urine by Screen method

0.00

0.21

0.0

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.8

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

0.00

0.21

0.0

1.5

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

0.00

0.21

0.0

1.3

—

(4268621)

0.00

0.21

0.0

1.9

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.00

0.21

0.0

1.8

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.21

0.0

1.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

0.00

0.21

0.0

1.6

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

0.00

0.21

0.0

1.6

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

0.00

0.21

0.0

1.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.28

0.21

1.2

1.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

0.00

0.20

0.0

1.5

—

(36304419) Bacteria [Presence] in Urine

150

1.18

0.17

3.7

2.7

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.22

0.16

1.2

1.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

104

1.19

0.13

1.1

1.3

1.8

12.1

u/ml

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1.21

0.13

3.5

2.2

12.4

13.3

umol/l

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1.18

0.10

1.2

2.0

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.13

0.08

2.0

1.5

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.07

0.08

2.1

1.5

—

(40768797) Stomach Pathology biopsy report

1.09

0.08

1.5

1.2

—

(40768804) Tissue Pathology biopsy report

211

0.92

0.05

2.1

2.0

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

101

1.11

0.04

2.5

1.9

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

303

1.05

0.01

2.9

3.0

—

(1761868) Lipid panel - Serum or Plasma

176

1.03

0.00

4.1

2.8

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.3

—

(3016018) Differential panel - Cerebral spinal fluid

0.00

0.0

1.0

—

(40768441) Liver Pathology biopsy report

0.00

0.0

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

0.0

1.2

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

0.00

0.0

1.3

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

4.7

—

15.3

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.0

1.7

—

(3005570) Glucose [Moles/volume] in Urine

0.00

0.0

2.5

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.00

0.0

1.7

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.3

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.3

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

0.00

0.0

2.0

—

4.5

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.3

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.3

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.00

0.0

1.1

—

(3023410) Appearance of Cerebral spinal fluid

0.00

0.0

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

0.00

0.0

1.4

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

0.00

0.0

1.8

—

16.2

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.00

0.0

1.0

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.00

0.0

3.6

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.00

0.0

1.4

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.00

0.0

1.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

0.00

0.0

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

0.00

0.0

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.00

0.0

1.0

—

(3005033) Fetal Nuchal fold Thickness US

0.00

0.0

1.6

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

0.00

0.0

1.6

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.00

0.0

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.0

1.0

—

118.6

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

0.0

1.6

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.00

0.0

1.6

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1.01

0.00

3.9

2.3

2.4

g/l

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

0.0

1.8

—

(4306422)

0.00

0.0

1.0

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

0.00

0.0

2.6

—

0.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

0.00

0.0

1.6

—

(3020491) Glucose [Moles/volume] in Blood

0.00

0.0

3.8

—

6.8

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.00

0.0

1.4

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

0.00

0.0

1.4

—

37.8

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

0.83

0.00

1.6

1.9

1.1

1.4

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.00

0.0

1.8

—

(3000494) Fungus identified in Specimen by Culture

0.91

0.00

1.3

1.5

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.00

0.0

1.6

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.00

0.0

1.6

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.00

0.0

1.6

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.00

0.0

1.6

—

(3042936) Bacteria identified in Isolate by Culture

1.03

0.00

2.0

2.2

—

(4146454)

0.00

0.0

2.8

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

0.00

0.0

1.0

—

98.9

—

(4027681)

0.00

0.0

1.0

—

(3000012) Reticulocyte production index

0.00

0.0

1.0

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.00

0.0

1.7

—

0.9

—

(3021788) Differential panel - Synovial fluid

0.00

0.0

1.3

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_ERYTH_ANNULCENTRIFUG and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have L12_ERYTH_ANNULCENTRIFUG.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: L12_ERYTH_ANNULCENTRIFUG – Erythema annulare centrifugum

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Erythema annulare centrifugum

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints